At meeting held on 12 August 2016
Alkem Laboratories announced that the Board of Directors of the Company at its meeting held on 12 August 2016 approved further investment upto Rs. 25 crore, in Equity shares of Cachet Pharmaceuticals, subsidiary of the Company.Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content